Keyphrases
Statins
100%
Prostate Cancer
100%
Prostate Cancer Screening
100%
Prostate-specific Antigen
100%
Screening Trials
100%
Cancer-specific
100%
Cholesterol-lowering Drugs
42%
Confidence Interval
28%
Relative Risk
28%
Hazard Ratio
28%
Total Prostate-specific Antigen
28%
Current Users
28%
Prostate Cancer Risk
28%
Inverse Association
14%
Dose Effect
14%
Statin Use
14%
Multivariable
14%
Prostate Radiotherapy
14%
Adjusted Hazard Ratio
14%
Advanced Prostate Cancer
14%
Age-adjusted
14%
Medication Use
14%
Cox Proportional Hazards Regression
14%
Prostate-specific Antigen Level
14%
Decreased Risk
14%
Prostate-specific Antigen Testing
14%
Cholesterol-lowering
14%
Early Tumor
14%
Dose Dependence
14%
Cholesterol-lowering Medication
14%
Prescription Database
14%
Cumulative Amount
14%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Prostate Specific Antigen
100%
Statin (Protein)
100%
Tumor Antigen
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
27%
Hypocholesterolemic Agent
27%
Cohort Study
9%
Cancer Staging
9%
Cancer Incidence
9%